Griffith Health

Injury to the nose increases risk of bacteria entering the brain – study

New research from Griffith University has shown that damage to the lining inside the nose increases the risk of bacteria sneaking into the brain via nerves, potentially causing long-term health issues. PhD candidate Heidi Walkden and her colleagues from the Menzies Health Institute Queensland, Institute for Glycomics and Griffith Institute for Drug Discovery, in collaboration with Queensland […]
Published
Institute for Glycomics

MBA Lawyers throw their support behind the Malaria Vaccine Project

MBA Lawyers, a long established and well-respected law firm based on the Gold Coast, has signed a memorandum of understanding to become a major corporate sponsor of the Malaria Vaccine Project. Established in March 2017, the Malaria Vaccine Project is a partnership between Rotary District 9640 and Griffith University’s Institute for Glycomics which aims to […]
Published
Griffith Enterprise

Researchers discover new treatments with potential to prevent and cure gonorrhoea in women

Researchers announce two new treatments with potential to prevent and cure gonorrhoea.
Published
Griffith Enterprise

Vital lymphoma research continues with Aust-German collaboration

Griffith’s Institute for Glycomics and Germany’s Bremen University have received funding to continue a research exchange to develop a drug delivery system to treat Non-Hodgkin’s Lymphoma.
Published
Institute for Glycomics

Inferring RNA structures by sequencing alone

Research done by Griffith University and the Hefei Institute of Material Science of the Chinese Academy of Sciences proposes that deep mutational scanning in combination with high throughput sequencing alone can be used to infer highly accurate structures for proteins and RNAs (Ribonucleic acids) without having to use expensive equipment. Understanding the structural clues behind […]
Published
Institute for Glycomics

Institute for Glycomics celebrates research excellence and 20th anniversary

Some of Griffith University’s most outstanding researchers have been honoured at the Institute for Glycomics Research Excellence Awards evening. Attended by more than one hundred guests, the aim of the cocktail-style presentation event was to acknowledge the Institute’s excellent research achievements and celebrate a remarkable milestone, the Institute for Glycomics 20th Anniversary. Awards from the […]
Published
home

Professor von Itzstein Gold Coast Citizen of the Year

Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has been honoured with the Gold Coast Citizen of the Year award.
Published
Griffith Enterprise

New treatment for viral arthritis reveals impressive results in Phase 2 human clinical trial

Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
Published
Griffith Enterprise

Meningococcal vaccine may reduce gonorrhoea incidence

A world-first trial for a promising gonorrhoea vaccine will be led by Griffith University’s Institute for Glycomics and the Kirby Institute at UNSW Sydney. The $2.7 million study incorporates five Australian universities and three health districts and providers, and will test whether a meningococcal B vaccine protects against gonorrhoea in gay and bisexual men. “Gonorrhoea […]
Published
Arts Education Law

Griffith awarded $3.3 million in funding for ARC Discovery and Linkage projects

Griffith University has been awarded $3,376,073 for ARC Discovery and Linkage Projects.
Published
Griffith Enterprise

Griffith and China Grand Pharma sign landmark deal to develop new drug for parainfluenza virus

Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
Published
Griffith Enterprise

Researchers use deep learning method to delve into predicting RNA structures in world first

Method to better predict RNA secondary structures could become tool to better understand implication in various diseases such as cancer. 
Published
Griffith Enterprise

Mushroom extracts could offer an immune cell boost

Shiitake, Reishi, and Maitake extracts enhance immune cell responses to boost overall immune system.
Published
Griffith Enterprise

Potential vaccine treats and prevents deadly streptococcal toxic shock

A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock caused by invasive streptococcal disease, which kills more than 160,000 people every year. “Streptococcal toxic shock syndrome is an acute condition like meningococcus – if you get exposed to the organism you can be dead […]
Published
Corporate

Griffith medical research to benefit from $5m funding 

NHMRC funding for Griffith researchers totals $5,167,963.
Published
Griffith Enterprise

Self-destructing cells could hold key for brain health and food security

‘Cell suicide’ study could unlock treatment for brain diseases and development of disease-resistant plants. 
Published
Architecture

Griffith scientists celebrate National Science Week 2019 

National Science Week will see a range of events celebrate Griffith's scientific expertise.
Published
Institute for Glycomics

Research provides new hope for treatment of Hand, Foot and Mouth Disease

A new scientific discovery, thanks to one of the research groups at Griffith University’s Institute for Glycomics, is providing new hope for the development of an effective treatment of Hand, Foot and Mouth Disease (HFMD). Led by the Institute’s Founder and Director, Professor Mark von Itzstein AO, the research group has just published a paper […]
Published